Ovarian cancer in infertility patients

Annals of Medicine, 30(6), 525-528

DOI 10.3109/07853899809002599 PMID 9920353

Abstract

The possibility that ovulation induction increases the risk of ovarian cancer remains unproven. However, recent studies suggest that both infertility and endometriosis may be independent risk factors. Despite the various case reports and epidemiological studies performed the association between the use of infertility drugs and ovarian cancer remains weak. The fact that the women who were the first to use ovulation agents are now reaching mid-life means that future studies should show whether any association exists. Hence, there is a need now for large prospective trials to be performed to establish whether an association between ovulation induction agents and ovarian cancer truly exists.

Topics

ovarian cancer risk ovulation induction drugs infertility, fertility treatment ovarian cancer epidemiological evidence, endometriosis independent risk factor ovarian malignancy, infertility drugs clomiphene ovarian cancer association, ovulation stimulation agents cancer risk prospective trials, Burmeister Healy ovarian cancer infertility patients review, ovarian cancer risk infertile women long-term follow-up, ovulation induction safety cancer epidemiology, infertility as independent risk factor ovarian cancer
PMID 9920353 9920353 DOI 10.3109/07853899809002599 10.3109/07853899809002599

Cite this article

Burmeister, L., & Healy, D. L. (1998). Ovarian cancer in infertility patients. *Annals of medicine*, *30*(6), 525-528. https://doi.org/10.3109/07853899809002599